Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Phase II data on FG-4592 presented at Kidney Week

Nov. 11, 2011

Sanofi and Regeneron report on phase II hypercholesterolemia program

Nov. 10, 2011

Unigene discloses topline phase II data on oral parathyroid hormone analogue

Nov. 10, 2011

Merck & Co. launches Nexplanon in U.S.

Nov. 10, 2011

EC grants marketing authorization to orphan drug for adrenal insufficiency in adults

Nov. 9, 2011

Lilly and Amylin reach agreement to terminate diabetes alliance

Nov. 9, 2011

Presentations provide further phase II data on lesinurad in gout

Nov. 9, 2011

Recordati's Normosang approved in Russia

Nov. 8, 2011

Novo Nordisk reports results from Japanese phase IIIa trial of DegludecPlus

Nov. 8, 2011

Evolva clear to begin phase IIa development of EV-077 in diabetic complications

Nov. 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...